Patents by Inventor Shawn Black

Shawn Black has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FCRN ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220144946
    Abstract: Methods for dosing of antibodies to human neonatal Fc receptor (FcRn) are described. The anti-FcRn antibodies are useful, e.g., to promote clearance of autoantibodies in a subject, to suppress antigen presentation in a subject, to block an immune response, e.g., block an immune complex-based activation of the immune response in a subject, or to treat immunological diseases (e.g., autoimmune diseases) in a subject.
    Type: Application
    Filed: November 5, 2021
    Publication date: May 12, 2022
    Inventors: Sindhu Ramchandran, Hong Sun, William Denney, Santiago Arroyo, Leona Ling, Jocelyn Leu, Jianhua Jin, Marie-Helene Jouvin, Keith Karcher, Shawn Black, Yaowei Zhu
  • Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
    Patent number: 6552168
    Abstract: The invention encompasses the novel class of compounds represented by formula I, which are caspase-3 inhibitors. The invention also encompasses certain pharmaceutical compositions for treatment of caspase-3 mediated diseases comprising compounds of formula I.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: April 22, 2003
    Assignee: Merck Frosst Canada & Co.
    Inventors: Erich L. Grimm, Johanne Renaud, Renee Aspiotis, Christopher I. Bayly, Robert Zamboni, Shawn Black